Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future Directions.

Li, Pei; Wang, Su; Chen, Yuwen

Li, Pei; Wang, Su; Chen, Yuwen.

Afiliación

Li P; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Wang S; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China. wangsu414@163.com.
Chen Y; Drug Regulatory Research Base of NMPA - Research Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China. wangsu414@163.com.

Ther Innov Regul Sci ; 58(1): 34-41, 2024 01.

Article en En | MEDLINE | ID: mdl-37996768

Asunto(s)

Medicina Tradicional China; Humanos; Predicción; China

Palabras clave

Current status and future directions; Evidence-based regulatory framework; Real-world evidence (RWE); Regulatory decisions; Traditional Chinese Medicine (TCM)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicina Tradicional China Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ther Innov Regul Sci Año: 2024 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google